Analyst Price Target is $25.88
▲ +105.68% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for SI-BONE in the last 3 months. The average price target is $25.88, with a high forecast of $36.00 and a low forecast of $17.00. The average price target represents a 105.68% upside from the last price of $12.58.
Current Consensus is
The current consensus among 7 contributing investment analysts is to buy stock in SI-BONE. This Buy consensus rating has held steady for over two years.
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.